PRESIDENT AND CHIEF EXECUTIVE OFFICER
Pharma Two B
William Marth, a Board member since March 2014, has served as the Chairman of the Board, president and Chief Executive Officer elect of Albany Molecular Research Inc. since May 2012, and has served as the Chairman of the Board of Directors of Sorrento Therapeutics since January 2014. Previously, Mr. Marth has served as President and Chief Executive Officer of Teva Pharmaceutical Industries Ltd. in the Americas from June 2010 to November 2012. From 2008 to 2009 he served as President and Chief Executive Officer of Teva North America, and as President and Chief Executive Officer of Teva USA from 2005 to 2008. From 1999 to 2002, Mr. Marth was the Executive Vice President and Vice President of Sales & Marketing for Teva USA. Prior to joining Teva USA, he held a range of positions with the Apothecon division of Bristol-Myers Squibb. In 2008, Mr. Marth was elected Chairman of the Generic Pharmaceutical Association where he also serves as a member of their executive committee. Mr. Marth is a licensed pharmacist and serves on various boards and committees, including The University of the Sciences in Philadelphia, the American Society for Health-System Pharmacists, and the Board of Ambassadors for John Hopkins’ Project RESTORE. Mr. Marth has been a member of the Research and Development Committee since May 2014. He earned his B.Sc. in pharmacy from the University of Illinois in 1977 and his M.B.A. in 1989 from DeVry University’s Keller Graduate School of Management.